Amarin Corp Plc (AMRN)

[ferretmoney]

Matinas is a wanabee and nothing more. As I recall, and I’m not interested in looking it up again, they ran a very short term very small ‘n’ phase 1? trial where their drug supposedly lowered triglycerides better than Vascepa. It’s an invalid premise on which to say their drug is superior. We all know on this board that the Vascepa effect gets better and better over time and the dose should be administered in accordance with the package instructions not, as I believe Matinas did, in a way to minimize the effect. They are 10 years and $1 billion to fund a long-term large scale outcome study away before they get bragging rights. I’m not buying it